← All trials
NCT03690583
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 29, 2014
- Primary completion
- Feb 18, 2016
- Completion date
- Feb 23, 2016
- First posted
- —
- Last posted
- —
- Enrollment
- 103
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- National Autonomous University of MexicoLead sponsor
- National Autonomous University of MexicoReponsible party - principal investigator
- National Autonomous University of MexicoCollaborator
- National Autonomous University of MexicoOverall official - principal investigator
- Pediatric Hospital CoyoacanCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.